CVS HEALTH (AND SUBSIDIARIES) for CVS HEALTH (AND SUBSIDIARIES)
What was lobbied
9 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Issues related to health savings accounts, the health insurance tax, and other taxes included in the Affordable Care Act. H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act S. 1948, The Chronic Disease Management Act of 2019 S. 3200, The Chronic Disease Management Act of 2020
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BROOKS | — |
| SHANNON PENBERTHY | — |
| SARAH SCHMIDT | — |
Copyright/Patent/Trademark CPT
Issues related to barriers to generic drug and biosimilar market entry. H.R. 985, The Fair Access for Safe and Timely Generics Act of 2019
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BROOKS | — |
| GLEN CHAMBERS | — |
| ROSALYN KUMAR | — |
| JOY MCGLAUN | — |
| AMY ROSENBAUM | — |
| SARAH SCHMIDT | — |
Health Issues HCR
Issues related to implementation and changes to the Affordable Care Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BROOKS | — |
| GLEN CHAMBERS | — |
| ROSALYN KUMAR | — |
| JOY MCGLAUN | — |
| SARAH SCHMIDT | — |
Postal POS
Issues related to the continuation and affordability of postal services. S. 2965, The USPS Fairness Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHANNON PENBERTHY | — |
Veterans VET
Issues related to implementation of the VA MISSION Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROSALYN KUMAR | — |
| SHANNON PENBERTHY | — |
Medicare/Medicaid MMM
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovative Devices Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BROOKS | — |
| GLEN CHAMBERS | — |
| ROSALYN KUMAR | — |
| JOY MCGLAUN | — |
| SHANNON PENBERTHY | — |
| AMY ROSENBAUM | — |
| SARAH SCHMIDT | — |
| MELISSA SCHULMAN | — |
Insurance INS
Issues related to employer, small group and individual insurance markets, including surprise billing. H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinants of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BROOKS | — |
| GLEN CHAMBERS | — |
| ROSALYN KUMAR | — |
| JOY MCGLAUN | — |
| SHANNON PENBERTHY | — |
| AMY ROSENBAUM | — |
| SARAH SCHMIDT | — |
| MELISSA SCHULMAN | — |
Labor Issues/Antitrust/Workplace LBR
Issues related to the competitive nature of the pharmacy benefit management industry. H.R. 2376/S. 1227, The Prescription Pricing for the People Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BROOKS | — |
| GLEN CHAMBERS | — |
| ROSALYN KUMAR | — |
| JOY MCGLAUN | — |
| SHANNON PENBERTHY | — |
| AMY ROSENBAUM | — |
| SARAH SCHMIDT | — |
Pharmacy PHA
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BROOKS | — |
| GLEN CHAMBERS | — |
| ROSALYN KUMAR | — |
| JOY MCGLAUN | — |
| SHANNON PENBERTHY | — |
| AMY ROSENBAUM | — |
| SARAH SCHMIDT | — |
| MELISSA SCHULMAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.